Literature DB >> 27656583

Serratiopeptidase - A Cause for Spread of Infection.

Prashanth Rajaram1, Abhishek Bhattacharjee2, Smriti Ticku2.   

Abstract

Serratiopeptidase is a proteolytic enzyme that has been used for reducing inflammation, it has antiedemic, analgesic, fibrinolytic and caesinolytic properties. Serratiopeptidase is often used in oral surgery for its anti-inflammatory purpose after impaction surgery, maxillofacial trauma and infections but its use should be limited in cases of abscess due to its fibrinolytic activity. Here, we report a case of a buccal space abscess which had spread into deeper muscular layers after serratiopeptidase administration in a 32-year-old male without any systemic condition. Patient presented with a painful swelling on the right mid region of the face since seven days. Serratiopeptidase was discontinued. After routine blood investigation and ultrasonography, incision and drainage was done and the patient recovered after seven days of treatment.

Entities:  

Keywords:  Abscess; Buccal space; Proteolytic enzyme

Year:  2016        PMID: 27656583      PMCID: PMC5028551          DOI: 10.7860/JCDR/2016/21388.8302

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  5 in total

Review 1.  Serratiopeptidase: a systematic review of the existing evidence.

Authors:  Shivani Bhagat; Monika Agarwal; Vandana Roy
Journal:  Int J Surg       Date:  2013-02-01       Impact factor: 6.071

2.  Intestinal absorption of serrapeptase (TSP) in rats.

Authors:  N Moriya; M Nakata; M Nakamura; M Takaoka; S Iwasa; K Kato; A Kakinuma
Journal:  Biotechnol Appl Biochem       Date:  1994-08       Impact factor: 2.431

3.  Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo.

Authors:  A Mazzone; M Catalani; M Costanzo; A Drusian; A Mandoli; S Russo; E Guarini; G Vesperini
Journal:  J Int Med Res       Date:  1990 Sep-Oct       Impact factor: 1.671

4.  Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation.

Authors:  N M Nirale; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

5.  Repression of fibrinolysis in scalded rats by administration of Serratia protease.

Authors:  A Kakinuma; N Moriya; K Kawahara; H Sugino
Journal:  Biochem Pharmacol       Date:  1982-09-15       Impact factor: 5.858

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.